title: Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
authors.affiliation: Department of Urology, Osaka University Hospital, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Jiang
authors.forename: S
authors.initials: S
authors.lastname: Takahara
authors.forename: Y
authors.initials: Y
authors.lastname: Takano
authors.forename: Y
authors.initials: Y
authors.lastname: Kokado
authors.forename: H
authors.initials: H
authors.lastname: Kameoka
authors.forename: A
authors.initials: A
authors.lastname: Moutabarrik
authors.forename: M
authors.initials: M
authors.lastname: Ishibashi
authors.forename: A
authors.initials: A
authors.lastname: Okuyama
authors.forename: T
authors.initials: T
authors.lastname: Sonoda
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D006146:Guanidines; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D003404:Creatinine; C037258:gusperimus; D008775:Methylprednisolone